| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 10,740 | 11,200 | 07.01. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Neue Studie: Personalisierte Implantate von Carlsmed senken Reoperationsrate bei Wirbelsäulen-OPs signifikant | 1 | Investing.com Deutsch | ||
| Di | Carlsmed's personalized implants reduce spine surgery reoperations | 1 | Investing.com | ||
| Di | Carlsmed aprevo Lumbar 2-year Data Published in Global Spine Journal | 1 | GlobeNewswire (USA) | ||
| 15.12.25 | Carlsmed stock holds Buy rating at BTIG as aprevo Cervical launch shows promise | 1 | Investing.com | ||
| 03.12.25 | Carlsmed launches Aprevo platform for cervical fusion surgeries | 1 | MassDevice | ||
| 03.12.25 | Carlsmed launches personalized cervical fusion implant system | 1 | Investing.com | ||
| CARLSMED Aktie jetzt für 0€ handeln | |||||
| 03.12.25 | Carlsmed Announces U.S. Launch of its aprevo Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting | 147 | GlobeNewswire (Europe) | CARLSBAD, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), today announced the U.S. commercial launch of its aprevo- Technology Platform for... ► Artikel lesen | |
| 27.11.25 | XFRA NEW INSTRUMENTS AVAILABLE ON 27.11.2025 | 416 | Xetra Newsboard | The following instruments on XETRA do have their first trading 27.11.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 27.11.2025
Aktien
1 CNE100003KK7 Rizhao Port Jurong Co.... ► Artikel lesen | |
| 06.11.25 | Carlsmed, Inc. GAAP EPS of -$0.40 beats by $0.02, revenue of $13.1M beats by $1.72M | 3 | Seeking Alpha | ||
| 06.11.25 | CARLSMED, INC. - 8-K, Current Report | - | SEC Filings | ||
| 30.10.25 | CARLSMED, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.09.25 | Carlsmed beruft Jenifer Kamocsay zur neuen Chief Legal Officer | 1 | Investing.com Deutsch | ||
| 29.09.25 | Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary | 160 | GlobeNewswire (Europe) | CARLSBAD, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions... ► Artikel lesen | |
| 22.09.25 | Carlsmed joins Russell 2000 Index following Q3 IPO | 1 | Seeking Alpha | ||
| 22.09.25 | Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index | 1 | GlobeNewswire (USA) | ||
| 29.08.25 | Carlsmed stock rating reiterated at Buy by Goldman Sachs on growth outlook | 2 | Investing.com | ||
| 29.08.25 | Goldman Sachs bestätigt Kaufempfehlung für Carlsmed angesichts starker Wachstumsaussichten | 1 | Investing.com Deutsch | ||
| 29.08.25 | Carlsmed, Inc. Q2 Sales Increase | 1 | RTTNews | ||
| 28.08.25 | Carlsmed: Umsatz im zweiten Quartal 2025 fast verdoppelt, Aktie legt zu | 2 | Investing.com Deutsch | ||
| 28.08.25 | CARLSMED, INC. - 10-Q, Quarterly Report | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,310 | +0,46 % | DEUTSCHE BANK RESEARCH stuft Siemens Healthineers auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für Siemens Healthineers auf "Hold" mit einem Kursziel von 46 Euro belassen. Er rechne damit, dass der Start in das neue Geschäftsjahr... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,180 | -2,59 % | EILMELDUNG: Fresenius Medical Care-Aktie im freien Fall - Anleger fliehen aus dem Wert! | ||
| FRESENIUS | 48,970 | +1,09 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 39,510 | -2,85 % | S&P Dow Jones Indices: BrightSpring Health Services Set to Join S&P SmallCap 600 | NEW YORK, Oct. 14, 2025 /PRNewswire/ -- BrightSpring Health Services Inc. (NASD: BTSG) will replace Veritex Holdings Inc. (NASD: VBTX) in the S&P SmallCap 600 effective... ► Artikel lesen | |
| PROGYNY | 26,800 | +0,49 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,200 | -0,94 % | Citizens reiterates Market Outperform rating on Privia Health stock | ||
| PROCEPT BIOROBOTICS | 33,920 | -2,30 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GENEDX | 136,55 | +0,55 % | GeneDx to launch whole genome sequencing test for fetal anomalies | ||
| HEARTFLOW | 32,580 | +4,42 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,640 | +0,71 % | EQS-PVR: Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Carl Zeiss Meditec AG
Carl Zeiss Meditec AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the... ► Artikel lesen | |
| BETA BIONICS | 31,490 | +0,35 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,300 | +0,14 % | LifeStance Health Group, Inc.: LifeStance Reports Third Quarter 2025 Results | SCOTTSDALE, Ariz., Nov. 06, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BILLIONTOONE | 89,44 | -5,78 % | BillionToOne, Inc.: BillionToOne Reports Third Quarter 2025 Results | MENLO PARK, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 8,870 | +5,66 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook | Third Quarter Revenue was $621.9 million, a 22.2% increase over the prior year periodThird Quarter Net income was $14.1 million compared to Net loss of $42.8 million for the prior year periodAdjusted... ► Artikel lesen | |
| GERRESHEIMER | 27,700 | -0,72 % | Gerresheimer Aktie: Einer der Rebound-Favoriten für 2026! | © Foto: Foto von Tima Miroshnichenko auf PexelsNach einem verheerenden Börsenjahr 2025 könnte die Gerresheimer-Aktie jetzt die große Überraschung werden.Der Pharmaverpackungs-Spezialist aus Düsseldorf... ► Artikel lesen |